Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion.
Volume
14
Pagination
1248547 - ?
DOI
10.3389/fimmu.2023.1248547
Journal
Front Immunol
Metadata
Show full item recordAbstract
Activation of pancreatic stellate cells (PSCs) to cancer-associated fibroblasts (CAFs) is responsible for the extensive desmoplastic reaction observed in PDAC stroma: a key driver of pancreatic ductal adenocarcinoma (PDAC) chemoresistance leading to poor prognosis. Specialized pro-resolving mediators (SPMs) are prime modulators of inflammation and its resolution, traditionally thought to be produced by immune cells. Using liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based lipid mediator profiling PSCs as well as primary human CAFs express enzymes and receptors to produce and respond to SPMs. Human PSC/CAF SPM secretion profile can be modulated by rendering these cells activated [transforming growth factor beta (TGF-β)] or quiescent [all-trans retinoic acid (ATRA)]. ATRA-induced nuclear translocation of arachidonate-15-lipoxygenase (ALOX15) was linked to increased production of n-3 docosapentaenoic acid-derived Resolvin D5 (RvD5n-3 DPA), among other SPMs. Inhibition of RvD5n-3 DPA formation increases cancer cell invasion, whereas addback of this molecule reduced activated PSC-mediated cancer cell invasion. We also observed that circulating concentrations of RvD5n-3 DPA levels were decreased in peripheral blood of metastatic PDAC patients when compared with those measured in plasma of non-metastatic PDAC patients. Together, these findings indicate that RvD5n-3 DPA may regulate cancer-stroma cross-talk and invasion.
Authors
Aguirre, GA; Goulart, MR; Barts Pancreas Tissue Bank; Dalli, J; Kocher, HMCollections
Language
Licence information
The following license files are associated with this item:
Related items
Showing items related by title, author, creator and subject.
-
Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion
Coleman, SJ; Chioni, A-M; Ghallab, M; Anderson, RK; Lemoine, NR; Kocher, HM; Grose, RP (2014-04) -
Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ductal adenocarcinoma.
Cutmore, LC; Brown, NF; Raj, D; Chauduri, S; Wang, P; Maher, J; Wang, Y; Lemoine, NR; Marshall, JF (2020-02-15)BACKGROUND: Death from pancreatic ductal adenocarcinoma (PDAC) is rising across the world and PDAC is predicted to be the second most common cause of cancer death in the USA by 2030. Development of effective biotherapies ... -
Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma
Di Maggio, F; Arumugam, P; Delvecchio, FR; Batista, S; Lechertier, T; Hodivala-Dilke, K; Kocher, HM (2016)